CHS-DRG支付方式下药物合理使用循证与应用策略研究  

Study on evidence-based and applied strategies for rational use of medications under the CHS-DRG paymentmodel

作　　者：魏俊丽[1] 罗晓[1] 刘也 李昕 崔璨[1] 吴凡 WEI Junli;LUO Xiao;LIU Ye;LI Xin;CUI Can;WU Fan(Beijing Friendship Hospital,Capital Medical University,Xicheng District,Beijing,100050,PRC)

机构地区：[1]首都医科大学附属北京友谊医院,北京市西城区100050

出　　处：《中国医院》2025年第2期1-5,共5页Chinese Hospitals

基　　金：国家卫生健康委医院管理研究所2022年医疗质量循证管理持续改进研究项目(YLZLXZ22G028);北京市医管中心培育项目(PG2023001)。

摘　　要：在CHS-DRG支付下,医院成本控制的能力决定着医院运营管理的效果。药品是医疗成本和临床治疗中不可或缺的一部分,如何能够平衡好药品成本与医疗质量是需要深入探讨的问题。本研究通过循证导向构建医院合理用药体系,以CHS-DRG病组和合理用药为切入点,充分发挥临床药师的专业特点,通过CHS-DRG付费下费用异常点监测路径以及CHS-DRG付费下合理用药事前、事中、事后管理探索,制定综合应用与管理策略路径,在促进住院用药规范化、同质化和保证医疗质量的基础上使药品成本稳定可控制,推动医院内涵式发展。Under the CHS-DRG payment model,a hospital's ability to control costs determines the effectiveness of its operations and management.Medications are an essential component of healthcare costs and clinical treatment,making it crucial to balance drug costs with the quality of care.This study aims to establish a rational drug use system guided by evidence-based principles,using CHS-DRG groups and rational drug use as entry points.By leveraging the expertise of clinical pharmacists,the study explores the monitoring of cost anomalies under the CHS-DRG payment model,as well as pre-,intra-,and post-management of rational drug use.The study formulates comprehensive application and management strategies to standardize and homogenize inpatient medication use,ensure medical quality,maintain stable and controllable drug costs,and promote the hospital's connotative development.

关 键 词：CHS-DRG 合理用药 循证药学 药事管理 

分 类 号：R197[医药卫生—卫生事业管理]